These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22249100)

  • 41. Prolongation of kidney allograft survival regulated by indoleamine 2, 3-dioxygenase in immature dendritic cells generated from recipient type bone marrow progenitors.
    Na N; Luo Y; Zhao D; Yang S; Hong L; Li H; Miao B; Qiu J
    Mol Immunol; 2016 Nov; 79():22-31. PubMed ID: 27689750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Active wound coverings: bioengineered skin and dermal substitutes.
    Límová M
    Surg Clin North Am; 2010 Dec; 90(6):1237-55. PubMed ID: 21074039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of the indoleamine 2,3-dioxygenase gene in preventing ovarian transplant rejection in rats†.
    Long A; Zhao S; Huang G; Li X; Cheng H; Chen Z; Hu Z; Zhu L; Zhao D; Hu X; Wang J
    Biol Reprod; 2024 Jul; 111(1):186-196. PubMed ID: 38452209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Local Burn Injury Promotes Defects in the Epidermal Lipid and Antimicrobial Peptide Barriers in Human Autograft Skin and Burn Margin: Implications for Burn Wound Healing and Graft Survival.
    Plichta JK; Holmes CJ; Gamelli RL; Radek KA
    J Burn Care Res; 2017; 38(1):e212-e226. PubMed ID: 27183442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Design principles for composition and performance of cultured skin substitutes.
    Boyce ST
    Burns; 2001 Aug; 27(5):523-33. PubMed ID: 11451611
    [No Abstract]   [Full Text] [Related]  

  • 46. CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase.
    Guillonneau C; Hill M; Hubert FX; Chiffoleau E; Hervé C; Li XL; Heslan M; Usal C; Tesson L; Ménoret S; Saoudi A; Le Mauff B; Josien R; Cuturi MC; Anegon I
    J Clin Invest; 2007 Apr; 117(4):1096-106. PubMed ID: 17404623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inducible expression of indoleamine 2,3-dioxygenase attenuates acute rejection of tissue-engineered lung allografts in rats.
    Ebrahimi A; Kardar GA; Teimoori-Toolabi L; Ghanbari H; Sadroddiny E
    Gene; 2016 Jan; 576(1 Pt 3):412-20. PubMed ID: 26506443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical use of acellular allogenic dermis or acellular porcine dermis with split-thickness autologous skin graft in 119 cases].
    Chai J; Yang H; Li L; Guo Z; Sheng Z; Xu M; Chen B; Jia X; Jing S; Lu J; Li G
    Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):790-3. PubMed ID: 11832167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of partial thickness facial burns (comparison of topical antibiotics and bio-engineered skin substitutes).
    Demling RH; DeSanti L
    Burns; 1999 May; 25(3):256-61. PubMed ID: 10323611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene therapy with adenovirus-delivered indoleamine 2,3-dioxygenase improves renal function and morphology following allogeneic kidney transplantation in rat.
    Vavrincova-Yaghi D; Deelman LE; Goor H; Seelen M; Kema IP; Smit-van Oosten A; Zeeuw D; Henning RH; Sandovici M
    J Gene Med; 2011 Jul; 13(7-8):373-81. PubMed ID: 21710661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is allograft skin, the gold-standard for burn skin substitute? A systematic literature review and meta-analysis.
    Paggiaro AO; Bastianelli R; Carvalho VF; Isaac C; Gemperli R
    J Plast Reconstr Aesthet Surg; 2019 Aug; 72(8):1245-1253. PubMed ID: 31176542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of indoleamine-2,3-dioxygenase in normal and pathological pregnancies.
    Chang RQ; Li DJ; Li MQ
    Am J Reprod Immunol; 2018 Apr; 79(4):e12786. PubMed ID: 29154462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blocking indoleamine dioxygenase activity early after rat liver transplantation prevents long-term survival but does not cause acute rejection.
    Laurence JM; Wang C; Park ET; Buchanan A; Clouston A; Allen RD; Mccaughan GW; Bishop GA; Sharland AF
    Transplantation; 2008 May; 85(9):1357-61. PubMed ID: 18475196
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suprathel, a new skin substitute, in the management of donor sites of split-thickness skin grafts: results of a clinical study.
    Schwarze H; Küntscher M; Uhlig C; Hierlemann H; Prantl L; Noack N; Hartmann B
    Burns; 2007 Nov; 33(7):850-4. PubMed ID: 17493762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA.
    Yen MC; Lin CC; Chen YL; Huang SS; Yang HJ; Chang CP; Lei HY; Lai MD
    Clin Cancer Res; 2009 Jan; 15(2):641-9. PubMed ID: 19147770
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical evaluation of skin substitutes.
    Kearney JN
    Burns; 2001 Aug; 27(5):545-51. PubMed ID: 11451613
    [No Abstract]   [Full Text] [Related]  

  • 57. Downregulation of indoleamine 2, 3-dioxygenase expression in the villous stromal endothelial cells of placentas with preeclampsia.
    Iwahashi N; Yamamoto M; Nanjo S; Toujima S; Minami S; Ino K
    J Reprod Immunol; 2017 Feb; 119():54-60. PubMed ID: 28131097
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Split skin graft application over an integrating, biodegradable temporizing polymer matrix: immediate and delayed.
    Greenwood JE; Dearman BL
    J Burn Care Res; 2012; 33(1):7-19. PubMed ID: 22079917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fetal fibroblasts and keratinocytes with immunosuppressive properties for allogeneic cell-based wound therapy.
    Zuliani T; Saiagh S; Knol AC; Esbelin J; Dréno B
    PLoS One; 2013; 8(7):e70408. PubMed ID: 23894651
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autologous mesenchymal stem cells prevent transplant arteriosclerosis by enhancing local expression of interleukin-10, interferon-γ, and indoleamine 2,3-dioxygenase.
    Jui HY; Lin CH; Hsu WT; Liu YR; Hsu RB; Chiang BL; Tseng WY; Chen MF; Wu KK; Lee CM
    Cell Transplant; 2012; 21(5):971-84. PubMed ID: 22449499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.